Hypocrellin B-based activatable photosensitizers for specific photodynamic effects against high H2O2-expressing cancer cells

A novel tumor-related biomarker, a H2O2-activatable photosensitizer 4 based on the 1,3-dicarbonyl enol moieties of hypocrellin B (3), was designed and synthesized. The photosensitizer 4 showed a blue-shifted absorption band compared with 3, and showed negligible photosensitizing ability without H2O2. However, the release of 3 from 4 by the reaction with H2O2 regenerated the photosensitizing ability. Furthermore, 4 exhibited selective and effective photo-cytotoxicity against high H2O2-expressing cancer cells upon photo-irradiation with 660 nm light, which is inside the phototherapeutic window.

Automated summary

A novel tumor-related biomarker, a H2O2-activatable photosensitizer 4 based on hypocrellin B (3), was synthesized. Photosensitizer 4 showed selective and effective photo-cytotoxicity against high H2O2-expressing cancer cells under 660 nm light irradiation, demonstrating potential for targeted cancer therapy.